Sutro Biopharma annual capital expenditures (capex)
2016
2017
2018
2022
2023
2024
2025
Sutro Biopharma Capital Expenditures (CapEx) Growth & History (STRO)
Sutro Biopharma's capital expenditures (capex) was $1.7M for fiscal 2025.
View full Sutro Biopharma company overviewSutro Biopharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | −$1.4M | −45.29% |
| 2024 | 2024-12-31 | $3.1M | −$1.2M | −28.20% |
| 2023 | 2023-12-31 | $4.3M | −$3.5M | −45.09% |
| 2022 | 2022-12-31 | $7.9M | — | — |
| 2018 | 2018-12-31 | $1.6M | −$1.8M | −53.05% |
| 2017 | 2017-12-31 | $3.3M | −$1.1M | −24.53% |
| 2016 | 2016-12-31 | $4.4M | — | — |
Sutro Biopharma quarterly capital expenditures (capex)
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q1.20
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $11,000 | −$1.2M | −99.06% |
| Q4 2025 | 2025-12-31 | $184,000 | — | — |
| Q3 2025 | 2025-09-30 | $251,000 | — | — |
| Q2 2025 | 2025-06-30 | $86,000 | — | — |
| Q1 2025 | 2025-03-31 | $1.2M | — | — |
| Q1 2020 | 2020-03-31 | $763,000 | $487,000 | +176.45% |
| Q3 2019 | 2019-09-30 | $667,000 | $308,000 | +85.79% |
| Q2 2019 | 2019-06-30 | $489,000 | $453,000 | +1258.33% |
| Q1 2019 | 2019-03-31 | $276,000 | −$88,000 | −24.18% |
| Q4 2018 | 2018-12-31 | $798,000 | — | — |
| Q3 2018 | 2018-09-30 | $359,000 | — | — |
| Q2 2018 | 2018-06-30 | $36,000 | — | — |
| Q1 2018 | 2018-03-31 | $364,000 | — | — |
Sutro Biopharma capital expenditures (capex) trends
Between the periods ended 2016-12-31 and 2025-12-31, Sutro Biopharma's capital expenditures (capex) decreased from $4.4M to $1.7M, a change of −$2.7M. The latest reported quarter, Q1 2026, shows $11,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sutro Biopharma source filings ↗